Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis.

Mori F, Tanji K, Miki Y, Wakabayashi K.

J Neuropathol Exp Neurol. 2009 Nov;68(11):1200-6. doi: 10.1097/NEN.0b013e3181bdcdce.

PMID:
19816197
[PubMed - indexed for MEDLINE]
2.

Applying proteomics to the diagnosis and treatment of ALS and related diseases.

Bowser R, Lacomis D.

Muscle Nerve. 2009 Nov;40(5):753-62. doi: 10.1002/mus.21488. Review.

PMID:
19670321
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cystatin C in cerebrospinal fluid as a biomarker of ALS.

Tsuji-Akimoto S, Yabe I, Niino M, Kikuchi S, Sasaki H.

Neurosci Lett. 2009 Mar 6;452(1):52-5.

PMID:
19444952
[PubMed - indexed for MEDLINE]
4.

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, Connor JR.

Neurology. 2009 Jan 6;72(1):14-9. doi: 10.1212/01.wnl.0000333251.36681.a5. Epub 2008 Nov 5.

PMID:
18987350
[PubMed - indexed for MEDLINE]
5.

Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis.

Keizman D, Rogowski O, Berliner S, Ish-Shalom M, Maimon N, Nefussy B, Artamonov I, Drory VE.

Acta Neurol Scand. 2009 Jun;119(6):383-9. doi: 10.1111/j.1600-0404.2008.01112.x. Epub 2008 Oct 23.

PMID:
18976328
[PubMed - indexed for MEDLINE]
6.

Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS).

Brettschneider J, Mogel H, Lehmensiek V, Ahlert T, Süssmuth S, Ludolph AC, Tumani H.

Neurochem Res. 2008 Nov;33(11):2358-63. doi: 10.1007/s11064-008-9742-5. Epub 2008 May 15.

PMID:
18481174
[PubMed - indexed for MEDLINE]
7.

Protein biomarkers for amyotrophic lateral sclerosis.

Ryberg H, Bowser R.

Expert Rev Proteomics. 2008 Apr;5(2):249-62. doi: 10.1586/14789450.5.2.249. Review.

PMID:
18466055
[PubMed - indexed for MEDLINE]
8.

EPO-KB: a searchable knowledge base of biomarker to protein links.

Lustgarten JL, Kimmel C, Ryberg H, Hogan W.

Bioinformatics. 2008 Jun 1;24(11):1418-9. doi: 10.1093/bioinformatics/btn125. Epub 2008 Apr 9.

PMID:
18400772
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Inflammatory markers in AD and MCI patients with different biomarker profiles.

Schuitemaker A, Dik MG, Veerhuis R, Scheltens P, Schoonenboom NS, Hack CE, Blankenstein MA, Jonker C.

Neurobiol Aging. 2009 Nov;30(11):1885-9. doi: 10.1016/j.neurobiolaging.2008.01.014. Epub 2008 Apr 18.

PMID:
18378357
[PubMed - indexed for MEDLINE]
10.

Cystatin C modulates cerebral beta-amyloidosis.

Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufenbiel M, Levy E, Grubb A, Jucker M.

Nat Genet. 2007 Dec;39(12):1437-9. Epub 2007 Nov 18.

PMID:
18026102
[PubMed - indexed for MEDLINE]
11.

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.

McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J, Lin DW, Malik G, Oelschlager D, Partin A, Randolph TW, Sokoll L, Srivastava S, Srivastava S, Thornquist M, Troyer D, Wright GL, Zhang Z, Zhu L, Semmes OJ.

Clin Chem. 2008 Jan;54(1):53-60. Epub 2007 Nov 16.

PMID:
18024530
[PubMed - indexed for MEDLINE]
Free Article
12.

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, Rosenzweig N, Srivastava S, Srivastava S, Thompson IM, Thornquist M, Troyer D, Yasui Y, Zhang Z, Zhu L, Semmes OJ.

Clin Chem. 2008 Jan;54(1):44-52. Epub 2007 Nov 2.

PMID:
17981926
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.

Kiehntopf M, Siegmund R, Deufel T.

Clin Chem Lab Med. 2007;45(11):1435-49. Review.

PMID:
17970700
[PubMed - indexed for MEDLINE]
14.

Targeted protein quantitation and profiling using PVDF affinity probe and MALDI-TOF MS.

Chen SH, Liao HK, Chang CY, Juo CG, Chen JH, Chan SI, Chen YJ.

Proteomics. 2007 Sep;7(17):3038-50.

PMID:
17676666
[PubMed - indexed for MEDLINE]
15.

Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):30-2. Epub 2007 Jul 18.

PMID:
17634215
[PubMed - indexed for MEDLINE]
16.

Amyotrophic lateral sclerosis.

Mitchell JD, Borasio GD.

Lancet. 2007 Jun 16;369(9578):2031-41. Review.

PMID:
17574095
[PubMed - indexed for MEDLINE]
17.

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

Simonsen AH, McGuire J, Podust VN, Davies H, Minthon L, Skoog I, Andreasen N, Wallin A, Waldemar G, Blennow K.

Neurobiol Aging. 2008 Jul;29(7):961-8. Epub 2007 Feb 23.

PMID:
17321007
[PubMed - indexed for MEDLINE]
18.

Oxidation inhibits amyloid fibril formation of transthyretin.

Maleknia SD, Reixach N, Buxbaum JN.

FEBS J. 2006 Dec;273(23):5400-6.

PMID:
17116243
[PubMed - indexed for MEDLINE]
19.

Cystatin C in cerebrospinal fluid and multiple sclerosis.

Hansson SF, Simonsen AH, Zetterberg H, Andersen O, Haghighi S, Fagerberg I, Andréasson U, Westman-Brinkmalm A, Wallin A, Rüetschi U, Blennow K.

Ann Neurol. 2007 Aug;62(2):193-6; discussion 205.

PMID:
16900522
[PubMed - indexed for MEDLINE]
20.

Quantitative multiplexed C-reactive protein mass spectrometric immunoassay.

Kiernan UA, Addobbati R, Nedelkov D, Nelson RW.

J Proteome Res. 2006 Jul;5(7):1682-7.

PMID:
16823976
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk